Nuclear medicine communicationsHumansMaleProstatic NeoplasmsAgedNeoplasm Staging
18F-DCFPyL and 18F-PSMA-JK7 for staging of primary prostate cancer: an interpatient comparison in 500 patients.
Maurits Wondergem, Friso M van der Zant, Sergiy V Lazarenko, Jeroen Doodeman, Ton A Roeleveld, Remco J J Knol
Published: 202510.1097/MNM.0000000000002027
Abstract
RATIONALE: Staging primary prostate cancer with prostate specific membrane antigen (PSMA) PET/computed tomography is incorporated in recent guidelines, given its pivotal role in guiding therapy selection and prognostication. Little is known about dif…
Preview only. Read the full abstract at the source